Search Results
Your search for ASCO matches 21586 pages
Showing 18001 - 18050Lung Cancer Screening Facts
The U.S. Preventive Services Task Force has posted a supplemental fact sheet for clinicians on its final recommendation statement on screening for lung cancer.1 This resource is meant to help health-care professionals talk about lung cancer screening with their patients and determine if screening...
Expert Point of View: Andrew D. Zelenetz, MD, PhD
Andrew D. Zelenetz, MD, PhD, Chair of the Non-Hodgkin Lymphoma Guideline Panel of the National Comprehensive Cancer Network (NCCN) and former Chief of the Lymphoma Service at Memorial Sloan-Kettering Cancer Center, New York, commented on the study by Yamshon et al for The ASCO Post. He said the...
Cancer Genes, Promiscuity, and the National Debt
There is no doubt that this is a halcyon period in oncology. The unraveling of the genome has been tremendously important, and finally has helped us to move treatment selection from an era of rational empiricism to one of refined, molecular prognostication. In the care of breast cancer, the impact...
Major Cancer Advances in 2013 Highlight Importance of Federal Funding
About one-third of the most important clinical advances in cancer last year were made possible at least in part through federal funding, according to ASCO’s annual report on progress in cancer, published in the Journal of Clinical Oncology.1 Significant Declines in Funding The report, “Clinical...
Addition of Carboplatin to Standard Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Supported by SABCS Studies
The achievement of a pathologic complete response in patients with triple-negative breast cancer was boosted by the addition of carboplatin to a standard neoadjuvant chemotherapy regimen, and by the addition of veliparib, an investigational oral PARP inhibitor, plus carboplatin to a standard...
Corrections to Note
In the January 15, 2014, issue of The ASCO Post, three errors occurred. These errors have since been corrected and revised versions of the articles may be viewed online at ASCOPost.com or via the QR code here. The errors were as follows below. Trastuzumab Dosing In the article “HER2-Positive...
Donald L. Morton, MD, an Icon in Surgical Oncology, Dies
“Tomorrow is the most important thing in life. Comes into us at midnight very clean. It’s perfect when it arrives and it puts itself in our hands. It hopes we’ve learned something from yesterday.” —John Wayne Donald L. Morton, MD, transformed the management of melanoma and breast cancer by...
Anticipated Shortage of Oncologists Will Strain Ability to Provide Quality Cancer Care
An update of the ASCO 2007 oncology workforce study found that the Patient Protection and Affordable Care Act, when fully implemented, may “modestly exacerbate” anticipated workforce shortages, increasing the demand for oncologists and radiation oncologists by 500,000 visits per year. “Unless...
Expect Questions from Patients
Like all early detection strategies, screening mammography involves trade-offs,” H. Gilbert Welch, MD, MPH, and Honor J. Passow, PhD, of the Dartmouth Institute for Health Policy & Clinical Practice, Hanover, New Hampshire, wrote in a Special Communication in JAMA Internal Medicine.1 They...
Confronting Uncertainty About the Harms and Benefits of Screening Mammography
“If women are to truly participate in the decision of whether or not to be screened [for breast cancer using mammography], they need some quantification of its benefits and harms,” asserted H. Gilbert Welch, MD, MPH, Professor of Medicine, and Honor J. Passow, PhD, Instructor, at The Dartmouth...
UN Agency Issues World Cancer Report 2014
A new global cancer report1 compiled by the United Nations’ International Agency for Research on Cancer (IARC) shows, as a single entity cancer is the biggest cause of mortality worldwide, and there were an estimated 8.2 million deaths from cancer in 2012. The report also noted that global cancer...
2014 Oncology Meetings
FEBRUARY European Society for Medical Oncology Sarcoma and GIST 2014February 18-19 • Milan, ItalyFor more information: www.esmo.org 2014 BMT Tandem MeetingAmerican Society for Blood and Marrow TransplantationFebruary 19 - 23 • Orlando, FloridaFor more information: www.asbmt.org Multidisciplinary...
NIH Names First Chief Officer for Scientific Workforce Diversity, Hannah Valantine, MD
National Institutes of Health (NIH) Director Francis S. Collins, MD, PhD, has appointed Hannah Valantine, MD, to Chief Officer for Scientific Workforce Diversity. Dr. Valantine will lead NIH’s effort to diversify the biomedical research workforce by developing a vision and comprehensive strategy...
Richard J. Gannotta, DHA, FACHE, Named President Northwestern Memorial Hospital
Northwestern Memorial HealthCare (NMHC) has announced that it has named Richard J. Gannotta, DHA, FACHE, President, Northwestern Memorial Hospital and Senior Vice President, NMHC effective this month. Dr. Gannotta was President of Duke Raleigh Hospital of the Duke University Health System. “Rick is ...
An Early Chemotherapy Innovator, Franco M. Muggia, MD, Now Focuses on Advancing Therapies for Ovarian Cancer
Looking over an illustrious career in medical oncology that spans 5 decades, Franco M. Muggia, MD, told The ASCO Post that he is excited about the future and hopes to continue making contributions to the field of oncology in years to come. At the forefront of the early clinical development of...
Focus on the Michigan Society of Hematology and Oncology
Founded nearly 3 decades ago in response to unfavorable changes in Medicare reimbursement regulations and growing coverage issues with Michigan’s private payers that threatened oncologists’ ability to provide quality cancer care to patients, the Michigan Society of Hematology and Oncology (MSHO)...
Milestones in Oncology, From ASCO’s CancerProgress.Net
To help tell the story of progress against cancer, ASCO launched CancerProgress.Net in 2011. The site is intended as a resource for media, policymakers, oncologists, advocates, and the public. One central feature of the site is an interactive timeline of major milestones in cancer treatment,...
Radiation Oncology Institute Awards $200,000 Grant to Christopher Slatore, MD
The Radiation Oncology Institute (ROI) has named Christopher G. Slatore, MD, recipient of a $200,000 award, distributed over 2 years, for a project to examine the comparative value of radiation therapy and patient outcomes among patients with lung cancer. Dr. Slatore is Assistant Professor in the...
City of Hope Receives $10 Million Gift to Launch Lymphoma Research and Treatment Center
A $10 million gift from Internet publishing entrepreneurs and philanthropists Emmet and Toni Stephenson and their daughter Tessa Stephenson Brand will fund the creation of the Toni Stephenson Lymphoma Center at City of Hope, Duarte, California, the cornerstone of the institution’s new Hematologic...
NIH Makes Palliative Care More Attainable for Pediatric Patients and Their Families
A campaign “Palliative Care: Conversations Matter” recently launched by the National Institute of Nursing Research (NINR) aims to increase the use of palliative care for children with serious illness. Palliative care can reduce a child’s pain, help manage other distressing symptoms, and provide...
Indiana University Simon Cancer Center Receives $15 Million Pledge
The Vera Bradley Foundation for Breast Cancer recently announced a $15 million pledge to support breast cancer research at the Indiana University Melvin and Bren Simon Cancer Center. This new pledge adds to the previous $20 million in commitments completed in November 2013 and will continue to fund ...
Impact of Comprehensive Lifestyle Change on Telomere Length and Telomerase Activity in Men With Low-Risk Prostate Cancer
Ornish et al at the University of California in San Francisco and the Preventive Medicine Research Institute in Sausalito, California, performed a 5-year study1 including 35 men on active surveillance (10 in a lifestyle-intervention group and 25 in a control group) with low-risk prostate cancer....
It’s Time to Reignite Our Nation’s Commitment to Cancer Research
As 2014 rolls in, ASCO is calling for a renewed commitment to federal funding of cancer research. In a letter sent to House and Senate Appropriations leaders, ASCO urged Congress to use spending levels in the recently passed budget to set the highest possible funding level for the National...
Charting the Successes: CancerProgress.Net Chronicles More Than 50 Years of ASCO and Progress Against Cancer
On this historic year, as ASCO proudly commemorates its 50th anniversary and decades of evolutionary change and growth, it also celebrates the significant progress that has been made against cancer throughout history. ASCO’s anniversary website, CancerProgress.Net, chronicles these achievements and ...
The Latest From the 2014 Genitourinary Symposium
Help your patients catch up on the latest research on genitourinary cancers—direct them to www.cancer .net/gusymposium for summaries of what the latest research means for patient care and a podcast with an ASCO expert explaining the importance of this research. They can also look for coverage of...
Conquer Cancer Foundation Launches New Planned Giving Website
In November of 2013, the Conquer Cancer Foundation partnered with the Stelter Company—one of the leaders of planned giving resources in the nonprofit community—to launch a new planned giving portal on the Foundation’s website. The planned giving portal focuses on the variety of ways individuals can ...
ASCO Turns Attention to Community Researchers With Community Research Forum
The implementation of clinical trials and quality research programs by community-based investigators and research staff is one of the most effective weapons available in the fight against cancer. The ASCO Community Research Forum was designed in support of this mission and to aid these...
Serving the Underserved: Dr. Gina Villani and ASCO’s Health Disparities Committee Work to Minimize Cancer Care Gaps
It has been a little over a decade since the Institute of Medicine landmark report Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care found overwhelming evidence of racial disparities in the U.S. health-care system. Since then, ASCO has been dedicated to minimizing these...
University of Pittsburgh Researchers Awarded More than $1 Million by NIH to Study New Treatments for Pancreatic Cancer Patients
The National Institutes of Health (NIH) has awarded a 5-year grant of more than $1.5 million to Herbert J. Zeh III, MD, and Michael T. Lotze, MD, at the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter, to study a novel treatment for pancreatic ductal ...
HER2 Testing: The Next Chapter
Late last year, the American Society of Clinical Oncology and College of American Pathologists published a comprehensive update of guidelines for HER2 testing,1 the first such update since their initial landmark publication in 2007.2 This new report, summarized in this issue of The ASCO Post,...
ASCO and College of American Pathologists Guideline Update: Recommendations for HER2 Testing in Breast Cancer
The American Society of Clinical Oncology (ASCO) and College of American Pathologists (CAP) recently convened an Update Committee to conduct a systematic literature review and update recommendations for optimal HER2 testing. In particular, the Committee identified criteria and areas requiring...
Longer-Term Follow-up of Breast Implant–Associated Anaplastic Large Cell Lymphoma: More Certainty About Certain Uncertainties
When what is now called breast implant–associated anaplastic large cell lymphoma was first recognized and initially described, a number of uncertainties prevailed—mainly, was the association with breast implants real, and was this a true lymphoma? Through the significant efforts of those who...
Expert Point of View: Andrew D. Zelenetz, MD, PhD
Andrew D. Zelenetz, MD, PhD, Chair of the Non-Hodgkin Lymphoma Guideline Panel of the National Comprehensive Cancer Network (NCCN) and former Chief of the Lymphoma Service at Memorial Sloan-Kettering Cancer Center, New York, put the latest maintenance trials into perspective for The ASCO Post....
Postmastectomy Pain Effectively Treated With a Simple Injection
For postmastectomy neuropathic pain, perineural infiltration with a combination of bupivacaine and dexamethasone is a “simple, effective, practice-changing treatment that any surgeon can do,” according to Laura J. Esserman, MD, MBA, Professor of Surgery and Radiology at the University of...
SABCS Highlights Include Findings in Triple-Negative Disease, Protective Effects of Exercise, and the Adherence-Copay Link
The San Antonio Breast Cancer Symposium brings together specialists from all over the world who focus on management of breast cancer. We have covered many of the important presentations in the pages of The ASCO Post and in our online Evening News. Below are summaries of additional noteworthy...
New Society Launched for Advanced Practitioners in Hematology and Oncology
The Advanced Practitioner Society for Hematology and Oncology (APSHO) announced its launch as a new organization focused on meeting the unique educational and professional needs of the advanced practitioner in hematology and oncology. The formation of the Society was made public on January 26,...
Margaret A. Tempero, MD, Named Editor-in-Chief of JNCCN
JNCCN – Journal of the National Comprehensive Cancer Network, the journal of the National Comprehensive Cancer Network (NCCN), has named Margaret A. Tempero, MD, as Editor-in-Chief. Dr. Tempero assumed the position of Editor-in-Chief on February 3, 2014, succeeding Harold J. Burstein, MD, PhD, who...
FDA Approves CliniMACS CD34 Reagent System for the Prevention of Graft-vs-Host Disease in AML
The U.S. Food and Drug Administration (FDA) has approved the Miltenyi Biotec’s CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-vs-host disease in patients with acute myeloid leukemia (AML) in first complete remission undergoing allogeneic stem cell...
FDA Accepts New Drug Application for Idelalisib in Refractory Indolent Non-Hodgkin Lymphoma
The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for idelalisib, a targeted, oral inhibitor of PI3K-delta, for the treatment of refractory indolent non-Hodgkin lymphoma (NHL). The FDA has granted a standard review for the NDA, with a target review date of...
Jamie H. Von Roenn, MD, and ASCO: A Perfect Fit
Dr. Von Roenn’s history with ASCO spans nearly 3 decades. She has served on ASCO’s Board of Directors, the ASCO Palliative Care Task Force, the Scientific Program, Cancer Education, and Cancer Communications Committees, among others. In 2011, Dr. Von Roenn received the ASCO-ACS Award at the Annual...
ASCO's Education and Professional Development Services
Last September, Jamie H. Von Roenn, MD, left her position as Professor of Medicine at the Northwestern University Feinberg School of Medicine in Chicago to join ASCO as its Senior Director of Education, Science and Professional Development. In her new position, Dr. Von Roenn will provide strategic...
Perspective on the Politics of Tobacco
The tobacco industry has always been a major player in congressional races, especially in Southern tobacco-growing states. Moreover, the industry is notoriously bipartisan in their political donations, and members of both parties have returned the favor by voting for tobacco interests. “The 2014...
The Surgeon General’s Report on Tobacco Turns 50: Much Success, Much Work Ahead
On January 11, 2014, the nation commemorated the 50th anniversary of a document that transformed our public health landscape and has saved millions of lives: Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. This groundbreaking report, which...
City of Hope’s New Chief Scientific Officer and Cancer Center Director Reflects on His Career Path and the Future of Cancer Care
City of Hope in Duarte, California, has named Steven T. Rosen, MD, as its first Provost and Chief Scientific Officer. Dr. Rosen will guide the scientific direction of the center’s medical research, treatment, and education. He will also assume directorship of the comprehensive cancer institute,...
David A. Fullerton, MD, Named President of The Society of Thoracic Surgeons
David A. Fullerton, MD, of the University of Colorado School of Medicine, was elected President of The Society of Thoracic Surgeons (STS) at the Society’s 50th Annual Meeting in Orlando, Florida. “STS has been a preeminent medical society for many years,” said Dr. Fullerton. “It is truly a great...
Cancer Treatment Centers Names Sr. Vice President, Patient Care Services
Cancer Treatment Centers of America in Philadelphia has announced they have recently hired Nancy G. Hesse, MSN, RN, as the hospital’s Senior Vice President of Patient Care Services. In her new role, Ms. Hesse will work on several key initiatives for her team related to engagement, communication,...
Dana-Farber Receives $900,000 Grant to Research Ovarian Cancer
The Ovarian Cancer Research Foundation has awarded researchers at Dana-Farber Cancer Institute a $900,000 grant to test new combinations of targeted drugs against the disease. Ursula Matulonis, MD, Director of the Gynecological Cancer Treatment Center in the Susan F. Smith Center for Women’s...
President’s Cancer Panel Issues Urgent Call to Action for HPV Vaccination
Achieving widespread human papillomavirus (HPV) vaccination is one of the most profound opportunities for cancer prevention, according to a report recently released by the President’s Cancer Panel. The Panel’s report, Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer, issues an ...
Advanced Practitioner Society for Hematology and Oncology (APSHO) Welcoming Members
The Advanced Practitioner Society for Hematology and Oncology (APSHO) is issuing a call for members to oncology nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, and pharmacists. The Society was launched recently during JADPRO Live, a meeting of the...
Cancer Pain: The Humbling Reality
As a medical oncologist and palliative care physician, I’ve had the privilege of caring for cancer patients and delivering primary palliative care and symptom control, as well as the chance to care for patients especially referred for complex pain and symptom problems (in secondary and even...
